Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Jul. 31, 2011	Jul. 31, 2010
Cash flow provided by (used in) operating activities:
Net income (loss)	$ 24,752	$ (53,853)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	17,123	13,955
Stock-based compensation	10,419	9,366
Excess tax benefits from stock-based compensation	0	(3,595)
Impairment of investment in unconsolidated entities	39,600
Income from unconsolidated entities and non-performing loan portfolio	(29,783)	(4,817)
Distributions of earnings from unconsolidated entities	7,417	7,211
Deferred tax benefit	4,329	(14,687)
Deferred tax valuation allowances	(4,329)	14,687
Inventory impairments	34,861	88,220
Change in fair value of mortgage loans receivable and derivative instruments	628	(537)
Expenses related to early retirement of debt	3,414	692
Changes in operating assets and liabilities
Increase in inventory	(208,204)	(142,109)
Origination of mortgage loans	(457,383)	(417,985)
Sale of mortgage loans	504,724	395,191
Decrease in restricted cash	36,681
(Increase) decrease in receivables, prepaid expenses and other assets	(2,955)	8,143
Increase (decrease) in customer deposits	18,090	(9,735)
Decrease in accounts payable and accrued expenses	(38,045)	(48,404)
Decrease in income tax refund recoverable	141,590	112,141
Decrease in income taxes payable	(56,461)	(16,410)
Net cash provided by (used in) operating activities	46,468	(62,526)
Cash flow used in investing activities:
Purchase of property and equipment - net	(6,927)	(1,452)
Purchase of marketable securities	(420,087)	(105,450)
Sale and redemption of marketable securities	318,372
Investment in and advances to unconsolidated entities and non-performing loan portfolio	(42,141)	(55,628)
Return of investments in unconsolidated entities	26,285	7,246
Net cash used in investing activities	(124,498)	(155,284)
Cash flow used in financing activities:
Proceeds from loans payable	666,659	610,071
Principal payments of loans payable	(715,131)	(691,776)
Redemption of senior subordinated notes	0	(47,872)
Redemption of senior notes	(48,437)	(36,064)
Proceeds from stock-based benefit plans	23,731	7,273
Excess tax benefits from stock-based compensation	0	3,595
Receipts related to noncontrolling interest	2,678
Purchase of treasury stock	(463)	(500)
Net cash used in financing activities	(70,963)	(155,273)
Net decrease in cash and cash equivalents	(148,993)	(373,083)
Cash and cash equivalents, beginning of period	1,039,060	1,807,718
Cash and cash equivalents, end of period	$ 890,067	$ 1,434,635